SB505124是TGFβ受体ALK4和ALK5抑制剂,IC50分别为129 nM和47 nM,还能抑制ALK7,但对ALK1,2,3和6无抑制性。
MoreTamoxifen citrate, a selective non-steroidal estrogen receptor antagonist, was approved by FDA as a drug that is utilized in the treatment of estrogen receptor–positive breast cancer. Tamoxifen Citrate是一种雌激素受体拮抗剂,与雌激素竞争性结合。
MoreEquol是是大豆的代谢物,是人类的一种重要的异黄酮,与5α-DHT特异性结合,对重组雌激素受体ERβ具有适度的亲和力。
MoreElacridar是P-糖蛋白抑制剂,在体内外实验中常作为工具化合物。
MoreOspemifene is a non-hormonal selective estrogen receptor modulator (SERM) which is used for the treatment of dyspareunia.
MoreSB505124是TGFβ受体ALK4和ALK5抑制剂,IC50分别为129 nM和47 nM,还能抑制ALK7,但对ALK1,2,3和6无抑制性。
MoreTamoxifen citrate, a selective non-steroidal estrogen receptor antagonist, was approved by FDA as a drug that is utilized in the treatment of estrogen receptor–positive breast cancer. Tamoxifen Citrate是一种雌激素受体拮抗剂,与雌激素竞争性结合。
MoreEquol是是大豆的代谢物,是人类的一种重要的异黄酮,与5α-DHT特异性结合,对重组雌激素受体ERβ具有适度的亲和力。
MoreElacridar是P-糖蛋白抑制剂,在体内外实验中常作为工具化合物。
MoreOspemifene is a non-hormonal selective estrogen receptor modulator (SERM) which is used for the treatment of dyspareunia.
More